Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.47 CAD | -1.42% | -4.93% | -12.15% |
Jun. 07 | Transcript : HLS Therapeutics Inc. - Shareholder/Analyst Call | |
May. 28 | HLS Therapeutics Notes Role of Pharmaceutical Support Programs on Persistence with Clozapine Treatment in Quebec Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.15% | 80.25M | |
+27.42% | 76.68B | |
-0.60% | 24.41B | |
+7.82% | 8.81B | |
+10.46% | 8.48B | |
-25.33% | 7.47B | |
+15.02% | 5.21B | |
+1.24% | 4.12B | |
-8.45% | 3.86B | |
-3.20% | 3.56B |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- HLS Therapeutics Downgraded to Hold at Stifel GMP on Revenue Concerns; Price Target Cut to C$5.00